Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 534
Filter
1.
Chemosphere ; 357: 142082, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38642776

ABSTRACT

Studies have shown that bisphenol S (BPS) is mainly present as its conjugated metabolites in human blood. However, the distribution of conjugated BPS metabolites in different human blood matrices has not been characterized. In this study, paired human serum and whole blood samples (n = 79) were collected from Chinese participants, and were measured for the occurrence of BPS and 4 BPS metabolites. BPS was detectable in 49% of human serum (

Subject(s)
Phenols , Sulfones , Humans , Phenols/blood , Phenols/metabolism , Sulfones/blood , Sulfones/metabolism , Male , Female , Environmental Pollutants/blood , Environmental Pollutants/metabolism , Adult , Glucuronides/blood , Glucuronides/metabolism , Sulfuric Acid Esters/blood , Middle Aged
2.
Appl Environ Microbiol ; 90(3): e0193123, 2024 Mar 20.
Article in English | MEDLINE | ID: mdl-38376171

ABSTRACT

White-rot fungi employ secreted carbohydrate-active enzymes (CAZymes) along with reactive oxygen species (ROS), like hydrogen peroxide (H2O2), to degrade lignocellulose in wood. H2O2 serves as a co-substrate for key oxidoreductases during the initial decay phase. While the degradation of lignocellulose by CAZymes is well documented, the impact of ROS on the oxidation of the secreted proteins remains unclear, and the identity of the oxidized proteins is unknown. Methionine (Met) can be oxidized to Met sulfoxide (MetO) or Met sulfone (MetO2) with potential deleterious, antioxidant, or regulatory effects. Other residues, like proline (Pro), can undergo carbonylation. Using the white-rot Pycnoporus cinnabarinus grown on aspen wood, we analyzed the Met content of the secreted proteins and their susceptibility to oxidation combining H218O2 with deep shotgun proteomics. Strikingly, their overall Met content was significantly lower (1.4%) compared to intracellular proteins (2.1%), a feature conserved in fungi but not in metazoans or plants. We evidenced that a catalase, widespread in white-rot fungi, protects the secreted proteins from oxidation. Our redox proteomics approach allowed the identification of 49 oxidizable Met and 40 oxidizable Pro residues within few secreted proteins, mostly CAZymes. Interestingly, many of them had several oxidized residues localized in hotspots. Some Met, including those in GH7 cellobiohydrolases, were oxidized up to 47%, with a substantial percentage of sulfone (13%). These Met are conserved in fungal homologs, suggesting important functional roles. Our findings reveal that white-rot fungi safeguard their secreted proteins by minimizing their Met content and by scavenging ROS and pinpoint redox-active residues in CAZymes.IMPORTANCEThe study of lignocellulose degradation by fungi is critical for understanding the ecological and industrial implications of wood decay. While carbohydrate-active enzymes (CAZymes) play a well-established role in lignocellulose degradation, the impact of hydrogen peroxide (H2O2) on secreted proteins remains unclear. This study aims at evaluating the effect of H2O2 on secreted proteins, focusing on the oxidation of methionine (Met). Using the model white-rot fungi Pycnoporus cinnabarinus grown on aspen wood, we showed that fungi protect their secreted proteins from oxidation by reducing their Met content and utilizing a secreted catalase to scavenge exogenous H2O2. The research identified key oxidizable Met within secreted CAZymes. Importantly, some Met, like those of GH7 cellobiohydrolases, undergone substantial oxidation levels suggesting important roles in lignocellulose degradation. These findings highlight the adaptive mechanisms employed by white-rot fungi to safeguard their secreted proteins during wood decay and emphasize the importance of these processes in lignocellulose breakdown.


Subject(s)
Basidiomycota , Hydrogen Peroxide , Polyporaceae , Catalase/metabolism , Hydrogen Peroxide/metabolism , Wood/microbiology , Reactive Oxygen Species/metabolism , Fungal Proteins/metabolism , Lignin/metabolism , Basidiomycota/metabolism , Oxidation-Reduction , Cellulose 1,4-beta-Cellobiosidase/metabolism , Carbohydrates , Methionine/metabolism , Sulfones/metabolism
3.
Acta Parasitol ; 68(3): 535-547, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37330945

ABSTRACT

PURPOSE: Fasciola hepatica is a globally distributed trematode that causes significant economic losses. Triclabendazole is the primary pharmacological treatment for this parasite. However, the increasing resistance to triclabendazole limits its efficacy. Previous pharmacodynamics studies suggested that triclabendazole acts by interacting mainly with the ß monomer of tubulin. METHODS: We used a high-quality method to model the six isotypes of F. hepatica ß-tubulin in the absence of three-dimensional structures. Molecular dockings were conducted to evaluate the destabilization regions in the molecule against the ligands triclabendazole, triclabendazole sulphoxide and triclabendazole sulphone. RESULTS: The nucleotide binding site demonstrates higher affinity than the binding sites of colchicine, albendazole, the T7 loop and pßVII (p < 0.05). We suggest that the binding of the ligands to the polymerization site of ß-tubulin can lead a microtubule disruption. Furthermore, we found that triclabendazole sulphone exhibited significantly higher binding affinity than other ligands (p < 0.05) across all isotypes of ß-tubulin. CONCLUSIONS: Our investigation has yielded new insight on the mechanism of action of triclabendazole and its sulphometabolites on F. hepatica ß-tubulin through computational tools. These findings have significant implications for ongoing scientific research ongoing towards the discovery of novel therapeutics to treat F. hepatica infections.


Subject(s)
Anthelmintics , Fasciola hepatica , Fascioliasis , Animals , Triclabendazole/pharmacology , Triclabendazole/metabolism , Triclabendazole/therapeutic use , Tubulin/genetics , Molecular Docking Simulation , Benzimidazoles/pharmacology , Benzimidazoles/chemistry , Benzimidazoles/metabolism , Ligands , Sulfones/metabolism , Sulfones/therapeutic use , Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Fascioliasis/parasitology
4.
Chemosphere ; 329: 138697, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37062394

ABSTRACT

Bisphenol S (BPS) analogues are a group of recently reported emerging contaminants in the environment. Bacteria are important components of food webs. However, the potential risks of BPS analogues in bacteria have not been fully addressed. The toxicity effects and related mechanisms of two BPS analogues with different molecular weights (2,4-bisphenol S (2,4-BPS) and bis-(3-allyl-4-hydroxyphenyl) sulfone (TGSA)) on Escherichia coli K12 were compared. The minimum inhibitory concentration (MIC) of 2,4-BPS in the wild-type of E. coli K12 was lower than that of TGSA. The membrane permeability of the wild-type increased significantly after exposed to the same concentrations (0.5-50 nmol L-1) of 2,4-BPS and TGSA. In addition, 2,4-BPS induced more significant changes in membrane permeability than TGSA. Hormetic effects of 2,4-BPS and TGSA in the wild-type strain were noted in the levels of outer membrane proteins (ompC and ompF), multidrug efflux pump acriflavine resistance B (acrB) and type II topoisomerases. Transcriptomic results indicated these two BPS analogues inhibited the function of ABC transporters. In contrast to TGSA, 2,4-BPS affected DNA replication, tricarboxylic acid cycle, oxidative phosphorylation, and inhibited energy metabolism. Compared with wild-type strain, the ΔacrB mutant strain showed enhanced susceptibility to 2,4-BPS and TGSA with their MICs reduced by 20% and 11%, respectively. Deletion of the acrB affected the growth characteristics and induced stronger oxidative stress than the wild-type strain when exposed to 2,4-BPS or TGSA. The results suggested that 2,4-BPS were more toxic to E. coli K12 than TGSA in the concentration range of 0.5-50 nmol L-1, which was supported by the evidence from their impacts on membrane permeability and efflux pumps.


Subject(s)
Escherichia coli K12 , Escherichia coli Proteins , Escherichia coli K12/genetics , Escherichia coli , Biological Transport , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Sulfones/toxicity , Sulfones/metabolism , Bacteria/metabolism , Permeability , Multidrug Resistance-Associated Proteins/genetics
5.
Sci Total Environ ; 868: 161660, 2023 Apr 10.
Article in English | MEDLINE | ID: mdl-36690098

ABSTRACT

Bisphenol S (BPS) has been followed with interest for its endocrine disrupting effects, but exploration on the reproductive system of adult females is lack of deep investigation. In the present study, adult female CD-1 mice were treated with BPS for 28 days at 300 µg/kg/day. After that, uteruses and ovaries were harvested for histopathological examination, RNA-seq analysis, and diseases risk prediction. Hematoxylin-eosin (H&E) staining results showed significant histological alterations in the uterus and ovary of the BPS-exposed mice. Bioinformatics analysis of the RNA-seq screened a certain number of differentially expressed genes (DEGs) in both uterus and ovary between BPS group and their corresponding vehicle control groups (Veh), respectively. Functional enrichment analysis of DEGs found that hormone metabolism and immunoinflammatory related pathways were enriched. Disease risk evaluation of the hub genes was performed and the results indicated that diseases associated with uterus and ovary were mainly related to tumors and cancers. Further pan cancer and ovarian cancer survival analysis based on human diseases database pointed out, Foxa1, Gata3, S100a8 and Shh for uterus, Itgam, Dhcr7, Fdps, Hmgcr, Hsd11b1, Hsd3b1, Ptges, F3, Fn1, Ptger4 and Srd5a1 for ovary were significant correlation with cancer. The findings suggest that BPS causes some histopathological changes, alters the expressions of hub genes, enhances uterine and ovarian tumors or even cancer risks.


Subject(s)
Ovary , Uterus , Mice , Animals , Female , Adult , Humans , Uterus/metabolism , Phenols/metabolism , Sulfones/metabolism
6.
Front Cell Infect Microbiol ; 12: 868338, 2022.
Article in English | MEDLINE | ID: mdl-35651751

ABSTRACT

Biofilm-associated implant infections represent a major challenge for healthcare systems around the world due to high patient burden and enormous costs incurred. Enterococcus faecalis (E. faecalis) is the most prevalent enterococcal species identified in biofilm-associated infections. The steadily growing areas of application of implants demand a solution for the control of bacterial infections. Therefore, the development of modified anti-microbial implant materials and the testing of the behavior of different relevant bacterial strains towards them display an indispensable task. Recently, we demonstrated an anti-microbial effect of zwitterionic modified silicone rubber (LSR) against Staphylococcus aureus. The aim of this study was to evaluate bacterial colonization and biofilm formation of another clinically relevant strain, E. faecalis, on this material in comparison to two of the most commonly used thermoplastic polyurethanes (TPUs) and other modified LSR surfaces. By generating growth curves, crystal violet, and fluorescence staining, as well as analyzing the expression of biofilm-associated genes, we demonstrated no anti-microbial activity of the investigated materials against E. faecalis. These results point to the fact that anti-microbial effects of novel implant materials do not always apply across the board to all bacterial strains.


Subject(s)
Bacterial Adhesion , Enterococcus faecalis , Bacteria , Biofilms , Humans , Polymers , Sulfones/metabolism
7.
J Agric Food Chem ; 70(20): 6072-6083, 2022 May 25.
Article in English | MEDLINE | ID: mdl-35576451

ABSTRACT

A thorough understanding of absorption, distribution, metabolism, and excretion (ADME) of insecticide candidates is essential in insecticide development and structural optimization. Here, ADME of pyraquinil, a novel insecticidal GABA receptor antagonist, in Plutella xylostella larvae during the accumulation phase and depuration phase was investigated separately using a combination of UHPLC-Q-Orbitrap, HPLC-MS/MS, and MALDI-MSI. Five new metabolites of pyraquinil were identified, and a metabolic pathway was proposed. The oxidative metabolite (pyraquinil-sulfone) was identified as the main metabolite and confirmed by its standard. Quantitative results showed that pyraquinil was taken up by the larvae rapidly and then undergone a cytochrome P450s-mediated oxidative transformation into pyraquinil-sulfone. Both fecal excretion and oxidative metabolism were demonstrated to be predominant ways to eliminate pyraquinil in P. xylostella larvae during accumulation, while oxidative metabolism followed by fecal excretion was probably the major pathway during depuration. MALDI-MSI revealed that pyraquinil was homogeneously distributed in the larvae, while pyraquinil-sulfone presented a continuous enrichment in the midgut during accumulation. Conversely, pyraquinil-sulfone located in hemolymph can be preferentially eliminated during depuration, suggesting its tissue tropism. It improves the understanding of the fate of pyraquinil in P. xylostella and provides useful information for insecticidal mechanism elucidation and structural optimization of pyraquinil.


Subject(s)
Insecticides , Moths , Animals , GABA Antagonists/pharmacology , Insecticide Resistance , Insecticides/metabolism , Insecticides/pharmacology , Larva , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Sulfones/metabolism , Tandem Mass Spectrometry
8.
Bioorg Med Chem Lett ; 53: 128414, 2021 12 01.
Article in English | MEDLINE | ID: mdl-34666187

ABSTRACT

S-Palmitoylation is a reversible post-translational lipid modification that regulates protein trafficking and signaling. The enzymatic depalmitoylation of proteins is inhibited by the beta-lactones Palmostatin M and B, which have been found to target several serine hydrolases. In efforts to better understand the mechanism of action of Palmostatin M, we describe herein the synthesis, chemical proteomic analysis, and functional characterization of analogs of this compound. We identify Palmostatin M analogs that maintain inhibitory activity in N-Ras depalmitoylation assays while displaying complementary reactivity across the serine hydrolase class as measured by activity-based protein profiling. Active Palmostatin M analogs inhibit the recently characterized ABHD17 subfamily of depalmitoylating enzymes, while sparing other candidate depalmitoylases such as LYPLA1 and LYPLA2. These findings improve our understanding of the structure-activity relationship of Palmostatin M and refine the set of serine hydrolase targets relevant to the compound's effects on N-Ras palmitoylation dynamics.


Subject(s)
Lactones/analysis , Propiolactone/analogs & derivatives , Proteomics , Sulfones/analysis , ras Proteins/metabolism , Humans , Lactones/metabolism , Lactones/pharmacology , Molecular Structure , Propiolactone/analysis , Propiolactone/metabolism , Propiolactone/pharmacology , Sulfones/metabolism , Sulfones/pharmacology , ras Proteins/antagonists & inhibitors , ras Proteins/chemistry
9.
Molecules ; 26(18)2021 Sep 16.
Article in English | MEDLINE | ID: mdl-34577103

ABSTRACT

Piglet coccidiosis due to Cystoisospora suis is a major cause of diarrhea and poor growth worldwide. It can effectively be controlled by application of toltrazuril (TZ), and oral formulations have been licensed for many years. Recently, the first parenteral formulation containing TZ in combination with iron (gleptoferron) was registered in the EU for the prevention of coccidiosis and iron deficiency anemia, conditions in suckling piglets requiring routine preventive measures. This study evaluated the absorption and distribution of TZ and its main metabolite, toltrazuril sulfone (TZ-SO2), in blood and intestinal tissues after single oral (20 mg/kg) or single intramuscular (45 mg/piglet) application of TZ. Fifty-six piglets were randomly allocated to the two treatment groups. Animals were sacrificed 1-, 5-, 13-, and 24-days post-treatment and TZ and TZ-SO2 levels were determined in blood, jejunal tissue, ileal tissue, and mixed jejunal and ileal content (IC) by high performance liquid chromatography (HPLC). Intramuscular application resulted in significantly higher and more sustained concentrations of both compounds in plasma, intestinal tissue, and IC. Higher concentrations after oral dosing were only observed one day after application of TZ in jejunum and IC. Toltrazuril was quickly metabolized to TZ-SO2 with maximum concentrations on day 13 for both applications. Remarkably, TZ and TZ-SO2 accumulated in the jejunum, the primary predilection site of C. suis, independently of the administration route, which is key to their antiparasitic effect.


Subject(s)
Coccidiostats/metabolism , Coccidiostats/pharmacokinetics , Intestinal Mucosa/metabolism , Sulfones/metabolism , Sulfones/pharmacokinetics , Triazines/metabolism , Triazines/pharmacokinetics , Administration, Oral , Animals , Body Weight/drug effects , Coccidiosis/prevention & control , Coccidiosis/veterinary , Coccidiostats/administration & dosage , Ileum/metabolism , Injections, Intramuscular , Jejunum/metabolism , Sulfones/administration & dosage , Swine , Swine Diseases/prevention & control , Triazines/administration & dosage
10.
J Med Chem ; 64(16): 12322-12358, 2021 08 26.
Article in English | MEDLINE | ID: mdl-34378914

ABSTRACT

Rhodesain is a major cysteine protease of Trypanosoma brucei rhodesiense, a pathogen causing Human African Trypanosomiasis, and a validated drug target. Recently, we reported the development of α-halovinylsulfones as a new class of covalent reversible cysteine protease inhibitors. Here, α-fluorovinylsulfones/-sulfonates were optimized for rhodesain based on molecular modeling approaches. 2d, the most potent and selective inhibitor in the series, shows a single-digit nanomolar affinity and high selectivity toward mammalian cathepsins B and L. Enzymatic dilution assays and MS experiments indicate that 2d is a slow-tight binder (Ki = 3 nM). Furthermore, the nonfluorinated 2d-(H) shows favorable metabolism and biodistribution by accumulation in mice brain tissue after intraperitoneal and oral administration. The highest antitrypanosomal activity was observed for inhibitors with an N-terminal 2,3-dihydrobenzo[b][1,4]dioxine group and a 4-Me-Phe residue in P2 (2e/4e) with nanomolar EC50 values (0.14/0.80 µM). The different mechanisms of reversible and irreversible inhibitors were explained using QM/MM calculations and MD simulations.


Subject(s)
Cysteine Endopeptidases/metabolism , Cysteine Proteinase Inhibitors/pharmacology , Sulfones/pharmacology , Sulfonic Acids/pharmacology , Trypanocidal Agents/pharmacology , Vinyl Compounds/pharmacology , Animals , Cysteine Endopeptidases/chemistry , Cysteine Proteinase Inhibitors/chemical synthesis , Cysteine Proteinase Inhibitors/metabolism , Cysteine Proteinase Inhibitors/toxicity , Enzyme Assays , Female , HeLa Cells , Humans , Kinetics , Male , Mice , Molecular Docking Simulation , Molecular Structure , Parasitic Sensitivity Tests , Protein Binding , Structure-Activity Relationship , Sulfones/chemical synthesis , Sulfones/metabolism , Sulfones/toxicity , Sulfonic Acids/chemical synthesis , Sulfonic Acids/metabolism , Sulfonic Acids/toxicity , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/metabolism , Trypanocidal Agents/toxicity , Trypanosoma brucei brucei/drug effects , Vinyl Compounds/chemical synthesis , Vinyl Compounds/metabolism , Vinyl Compounds/toxicity
11.
Nat Commun ; 12(1): 3474, 2021 06 09.
Article in English | MEDLINE | ID: mdl-34108458

ABSTRACT

Sodium/proton exchanger 1 (NHE1) is an electroneutral secondary active transporter present on the plasma membrane of most mammalian cells and plays critical roles in regulating intracellular pH and volume homeostasis. Calcineurin B-homologous protein 1 (CHP1) is an obligate binding partner that promotes NHE1 biosynthetic maturation, cell surface expression and pH-sensitivity. Dysfunctions of either protein are associated with neurological disorders. Here, we elucidate structures of the human NHE1-CHP1 complex in both inward- and inhibitor (cariporide)-bound outward-facing conformations. We find that NHE1 assembles as a symmetrical homodimer, with each subunit undergoing an elevator-like conformational change during cation exchange. The cryo-EM map reveals the binding site for the NHE1 inhibitor cariporide, illustrating how inhibitors block transport activity. The CHP1 molecule differentially associates with these two conformational states of each NHE1 monomer, and this association difference probably underlies the regulation of NHE1 pH-sensitivity by CHP1.


Subject(s)
Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/metabolism , Sodium-Hydrogen Exchanger 1/chemistry , Sodium-Hydrogen Exchanger 1/metabolism , Binding Sites , Biological Transport , Cryoelectron Microscopy , Guanidines/metabolism , Humans , Models, Molecular , Multiprotein Complexes , Protein Binding , Protein Conformation , Protein Multimerization , Sodium-Hydrogen Exchanger 1/antagonists & inhibitors , Sulfones/metabolism
12.
Chem Res Toxicol ; 34(6): 1578-1587, 2021 06 21.
Article in English | MEDLINE | ID: mdl-34019419

ABSTRACT

Toxic effects induced upon exposure to low-dose bisphenol A (BPA) or bisphenol S (BPS) remains controversial. In this study, metabolomics was used to examine the metabolomic perturbation arising from 28 days of exposure to BPA or BPS at 50 µg/kg bw/day in Sprague-Dawley (SD) rats. Endogenous metabolite profiling revealed a clear discrimination of metabolome in the rat plasma among BPA-treatment, BPS-treatment, and control groups. BPA exposure induced the up-regulation of 19 metabolites and down-regulation of 32 metabolites in plasma of SD rats, compared with the control. BPS exposure induced the up-regulation of 15 metabolites and the down-regulation of 33 metabolites in the plasma of SD rats, compared with the control. Joint pathway analysis suggested marked perturbations in the citrate cycle, butanoate metabolism, and alanine, aspartate, and glutamate metabolism for BPA-exposed rats as well as glycerophospholipid metabolism for BPS-exposed rats. These findings provide novel insights into associations between the metabolomic perturbation and phenotypic changes arising from BPA and BPS exposure.


Subject(s)
Benzhydryl Compounds/pharmacology , Phenols/pharmacology , Sulfones/pharmacology , Alanine/metabolism , Animals , Aspartic Acid/metabolism , Benzhydryl Compounds/administration & dosage , Benzhydryl Compounds/metabolism , Butyrates/metabolism , Citric Acid Cycle/drug effects , Dose-Response Relationship, Drug , Glutamic Acid/metabolism , Glycerophospholipids , Male , Phenols/administration & dosage , Phenols/metabolism , Rats , Rats, Sprague-Dawley , Sulfones/administration & dosage , Sulfones/metabolism
13.
Future Med Chem ; 13(8): 691-700, 2021 04.
Article in English | MEDLINE | ID: mdl-33715419

ABSTRACT

Aim: To identify virtual bioisosteric replacements of two GPR40 agonists. Materials & methods: Bioinformatic docking of candidate molecules featuring a wide range of carboxylic acid bioisosteres into complex with GPR40 was performed using TAK-875 and GW9508 templates. Results: This study suggests that 2,6-difluorophenol and squaric acid motifs are the preferred bioisosteric groups for conferring GPR40 affinity. Conclusion: This study suggests that compounds 10 and 20 are worthy synthetic targets.


Subject(s)
Benzofurans/pharmacology , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/chemistry , Methylamines/pharmacology , Propionates/pharmacology , Receptors, G-Protein-Coupled/agonists , Sulfones/pharmacology , Animals , Benzofurans/metabolism , Cyclobutanes/chemistry , Humans , Hypoglycemic Agents/pharmacology , Methylamines/metabolism , Molecular Docking Simulation , Phenols/chemistry , Propionates/metabolism , Protein Binding , Protein Conformation , Sulfones/metabolism
14.
Toxicol Appl Pharmacol ; 413: 115409, 2021 02 15.
Article in English | MEDLINE | ID: mdl-33476676

ABSTRACT

There is increasing evidence that bisphenols BPS and BPF, which are analogues of BPA, have deleterious effects on reproduction even at extremely low doses. Indirect exposure via the maternal route (i.e. across the placenta and/or by breastfeeding) is underestimated, although it can be assumed to be a cause of idiopathic female infertility. Therefore, we hypothesised the deleterious effects of exposure to BPA analogues during breastfeeding on the ovarian and oocyte quality of offspring. A 15-day exposure period of pups was designed, whilst nursing dams (N ≥ 6 per experimental group) were treated via drinking water with a low (0.2 ng/g body weight/day) or moderate (20 ng/g body weight/day) dose of bisphenol, mimicking real exposure in humans. Thereafter, female pups were bred to 60 days and oocytes were collected. Immature oocytes were used in the in-vitro maturation assay; alternatively, in-vivo-matured oocytes were isolated and used for parthenogenetic activation. Both in-vitro- and in-vivo-matured oocytes were subjected to immunostaining of spindle microtubules (α-tubulin) and demethylation of histone H3 on the lysine K27 (H3K27me2) residue. Although very low doses of both BPS and BPF did not affect the quality of ovarian histology, spindle formation and epigenetic signs were affected. Notably, in-vitro-matured oocytes were significantly sensitive to both doses of BPS and BPF. Although no significant differences in spindle-chromatin quality were identified in ovulated and in-vivo-matured oocytes, developmental competence was significantly damaged. Taken together, our mouse model provides evidence that bisphenol analogues represent a risk to human reproduction, possibly leading to idiopathic infertility in women.


Subject(s)
Benzhydryl Compounds/toxicity , Fertility/drug effects , Infertility, Female/chemically induced , Lactation/metabolism , Milk/metabolism , Oocytes/drug effects , Ovary/drug effects , Phenols/toxicity , Sulfones/toxicity , Animals , Animals, Suckling , Benzhydryl Compounds/metabolism , Epigenesis, Genetic , Female , Gene Expression Regulation, Developmental , In Vitro Oocyte Maturation Techniques , Infertility, Female/metabolism , Infertility, Female/pathology , Infertility, Female/physiopathology , Maternal Exposure , Mice, Inbred ICR , Oocytes/metabolism , Oocytes/pathology , Ovarian Reserve/drug effects , Ovary/metabolism , Ovary/physiopathology , Phenols/metabolism , Pregnancy , Risk Assessment , Spindle Apparatus/drug effects , Spindle Apparatus/metabolism , Spindle Apparatus/pathology , Sulfones/metabolism
15.
Angew Chem Int Ed Engl ; 60(6): 3071-3079, 2021 02 08.
Article in English | MEDLINE | ID: mdl-33035395

ABSTRACT

Herein, we report arylazopyrazole ureas and sulfones as a novel class of photoswitchable serine hydrolase inhibitors and present a chemoproteomic platform for rapid discovery of optically controlled serine hydrolase targets in complex proteomes. Specifically, we identify highly potent and selective photoswitchable inhibitors of the drug-metabolizing enzymes carboxylesterases 1 and 2 and demonstrate their pharmacological application by optically controlling the metabolism of the immunosuppressant drug mycophenolate mofetil. Collectively, this proof-of-concept study provides a first example of photopharmacological tools to optically control drug metabolism by modulating the activity of a metabolizing enzyme. Our arylazopyrazole ureas and sulfones offer synthetically accessible scaffolds that can be expanded to identify specific photoswitchable inhibitors for other serine hydrolases, including lipases, peptidases, and proteases. Our chemoproteomic platform can be applied to other photoswitches and scaffolds to achieve optical control over diverse protein classes.


Subject(s)
Carboxylesterase/antagonists & inhibitors , Enzyme Inhibitors/chemistry , Pharmaceutical Preparations/metabolism , Ultraviolet Rays , Caco-2 Cells , Carboxylesterase/metabolism , Carboxylic Ester Hydrolases/antagonists & inhibitors , Carboxylic Ester Hydrolases/genetics , Carboxylic Ester Hydrolases/metabolism , Drug Evaluation, Preclinical , Enzyme Inhibitors/metabolism , Humans , Hydrolysis , Microscopy, Fluorescence , Pharmaceutical Preparations/chemistry , RNA Interference , RNA, Small Interfering/metabolism , Stereoisomerism , Sulfones/chemistry , Sulfones/metabolism , Urease/chemistry , Urease/metabolism
16.
Cancer Chemother Pharmacol ; 86(5): 589-594, 2020 11.
Article in English | MEDLINE | ID: mdl-32960289

ABSTRACT

PURPOSE: Monepantel is an approved veterinary anthelmintic with a strong safety profile. Preclinical evidence suggests novel mTOR pathway-associated anticancer activity. An open-label Phase I trial assessed tolerability, pharmacokinetics, pharmacodynamics and PET-CT imaging following oral Zolvix® monepantel administration to adults with treatment refractory, progressing and unresectable solid tumors. METHODS: Subjects were scheduled to daily home-based monepantel administration for 28 days in a 3 + 3 dose escalation study (5.0, 25.0 and 62.5 mg/kg bw). RESULTS: Of 41 reported drug-related AEs, 68% were Grade 1 and 24% were Grade 2; 35 AEs related to gastrointestinal effects including very poor palatability. DLT and MTD could not be determined due to early termination. Myelosuppression was not observed at the lowest level tested. Three of four Cohort 1 subjects had reduced mTOR pathway marker p-RPS6KB1 levels in PBMCs and achieved RECISTv1.1 SD by CT; one had progressive bony metastases by FDG-PET. One subject recorded PD on day 28, correlating with no detectable plasma monepantel from day 7. Monepantel sulfone dominated monepantel in pharmacokinetics. Both Cohort 2 subjects withdrew early due to AEs and the trial was terminated. CONCLUSIONS: Short-term 5 mg/kg bw monepantel administration provides a combined steady-state trough plasma monepantel and monepantel sulfone concentration of 0.5 µM. Gastrointestinal AEs including very poor palatability are concerning and suggested to be resolved by future drug product reformulation. RECISTv1.1, p-RPS6KB1 and plasma tumor marker outcomes provide preliminary evidence of anticancer activity.


Subject(s)
Aminoacetonitrile/analogs & derivatives , Neoplasms/drug therapy , Veterinary Drugs/toxicity , Administration, Oral , Adult , Aminoacetonitrile/administration & dosage , Aminoacetonitrile/metabolism , Aminoacetonitrile/pharmacokinetics , Aminoacetonitrile/toxicity , Cell Line, Tumor , Dose-Response Relationship, Drug , Drug Resistance, Neoplasm , Early Termination of Clinical Trials , Female , Humans , Inhibitory Concentration 50 , Male , Maximum Tolerated Dose , Neoplasms/blood , Neoplasms/diagnosis , Neoplasms/pathology , Positron Emission Tomography Computed Tomography , Sulfones/metabolism , Sulfones/pharmacokinetics , Sulfones/toxicity , TOR Serine-Threonine Kinases/antagonists & inhibitors , Veterinary Drugs/administration & dosage , Veterinary Drugs/pharmacokinetics
17.
Eur J Med Chem ; 208: 112696, 2020 Dec 15.
Article in English | MEDLINE | ID: mdl-32883642

ABSTRACT

We designed and synthesized 21 new indolylarylsulfones (IASs) as new HIV-1 NNRTIs. Among these, IAS 12 exhibited a remarkable antiviral activity against single and double mutants (K103N EC50 = <0.7 nM; Y181C EC50 = <0.7 nM; Y188L EC50 = 21.3 nM; K103N-Y181C EC50 = 6.2 nM), resulting equally or more active than previuosly reported IAS 6 and some approved anti-HIV-1 drugs. Docking and molecular dynamics simulations of compound 12 in complex with WT, Y181C, Y188L, K103N and K103N-Y181C RTs clarified a general binding mode that was consistent with biological results. Kinetic experiments disclosed that derivative 12 preferentially binds WT and K103N-Y181C RTs to binary and ternary complexes, respectively.


Subject(s)
Anti-HIV Agents/pharmacology , HIV-1/drug effects , Indoles/pharmacology , Reverse Transcriptase Inhibitors/pharmacology , Sulfones/pharmacology , Anti-HIV Agents/chemical synthesis , Anti-HIV Agents/metabolism , Cell Line, Tumor , Drug Design , Drug Synergism , HIV Reverse Transcriptase/metabolism , HIV-1/genetics , Humans , Indoles/chemical synthesis , Indoles/metabolism , Microbial Sensitivity Tests , Molecular Docking Simulation , Molecular Dynamics Simulation , Molecular Structure , Mutation , Protein Binding , Reverse Transcriptase Inhibitors/chemical synthesis , Reverse Transcriptase Inhibitors/metabolism , Structure-Activity Relationship , Sulfones/chemical synthesis , Sulfones/metabolism , Zidovudine/analogs & derivatives , Zidovudine/pharmacology
18.
Chemistry ; 26(68): 15855-15858, 2020 Dec 04.
Article in English | MEDLINE | ID: mdl-32996646

ABSTRACT

The anaerobe Clostridium acetobutylicum belongs to the most important industrially used bacteria. Whereas genome mining points to a high potential for secondary metabolism in C. acetobutylicum, the functions of most biosynthetic gene clusters are cryptic. We report that the addition of supra-physiological concentrations of cysteine triggered the formation of a novel natural product, clostrisulfone (1). Its structure was fully elucidated by NMR, MS and the chemical synthesis of a reference compound. Clostrisulfone is the first reported natural product with a diphenylsulfone scaffold. A biomimetic synthesis suggests that pentamethylchromanol-derived radicals capture sulfur dioxide to form 1. In a cell-based assay using murine macrophages a biphasic and dose-dependent regulation of the LPS-induced release of nitric oxide was observed in the presence of 1.


Subject(s)
Clostridium acetobutylicum , Immunologic Factors , Sulfones , Animals , Clostridium acetobutylicum/chemistry , Clostridium acetobutylicum/drug effects , Clostridium acetobutylicum/genetics , Clostridium acetobutylicum/metabolism , Cysteine/pharmacology , Immunologic Factors/metabolism , Immunologic Factors/pharmacology , Macrophages/drug effects , Mice , Multigene Family , Sulfones/metabolism , Sulfones/pharmacology
19.
Article in English | MEDLINE | ID: mdl-32787691

ABSTRACT

In this study, we established a rapid and sensitive HPLC-MS/MS method for quantitative determination of tembotrione and its metabolite AE 1417268 (M5) in corn, corn oil, beef, pork, chicken, and eggs. Both analytes eluted from a C18 column within 6 min. The electrospray ionisation-positive mode was used for tembotrione, whereas the negative mode was used for M5. Acetonitrile was the extractant for all samples, and the addition of 2 g NaCl to each homogenised sample facilitated the extraction of the analytes into acetonitrile. The extracted analytes were further purified by the addition of 50 mg of C18 sorbent (25 mg GCB was also added to corn samples) for subsequent HPLC-MS/MS analysis. Satisfactory calibration-curve linearities (R2 ≥ 0.997) were obtained for the two analytes at concentrations of 1-500 µg/L. Mean recoveries in different matrices ranged from 73.7% to 110.4%, whereas intra-day and inter-day relative standard deviations were <15% for all concentrations of spiked analytes. The limit of quantification was 2 µg/kg for each analyte in all matrices. In food samples obtained from markets, residual tembotrione and M5 were all below the limits of quantification. These results confirm that the method is suitable for the routine monitoring of residual tembotrione and M5 in a variety of food matrices.


Subject(s)
Corn Oil/analysis , Cyclohexanones/analysis , Food Contamination/analysis , Sulfones/analysis , Zea mays/chemistry , Animals , Cattle , Chickens , Chromatography, High Pressure Liquid , Cyclohexanones/metabolism , Eggs/analysis , Molecular Structure , Sulfones/metabolism , Tandem Mass Spectrometry
20.
Bioorg Med Chem Lett ; 30(19): 127441, 2020 10 01.
Article in English | MEDLINE | ID: mdl-32736080

ABSTRACT

In an effort to discover oral inverse agonists of RORγt to treat inflammatory diseases, a new 2,6-difluorobenzyl ether series of cyclopentyl sulfones were found to be surprisingly more potent than the corresponding alcohol derivatives. When combined with a more optimized phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone template, the 2,6-difluorobenzyl ethers yielded a set of very potent RORγt inverse agonists (e.g., compound 26, RORγt Gal4 EC50 11 nM) that are highly selective against PXR, LXRα and LXRß. After optimizing for stability in human and mouse liver microsomes, compounds 29 and 38 were evaluated in vivo and found to have good oral bioavailability (56% and 101%, respectively) in mice. X-ray co-crystal structure of compound 27 in RORγt revealed that the bulky benzyl ether group causes helix 11 of the protein to partially uncoil to create a new, enlarged binding site, which nicely accommodates the benzyl ether moiety, leading to net potency gain.


Subject(s)
Nuclear Receptor Subfamily 1, Group F, Member 3/antagonists & inhibitors , Pyrrolidines/pharmacology , Sulfones/pharmacology , Animals , Crystallography, X-Ray , Drug Discovery , Drug Inverse Agonism , Drug Stability , Hep G2 Cells , Humans , Mice , Microsomes, Liver/metabolism , Molecular Structure , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , Pyrrolidines/chemical synthesis , Pyrrolidines/metabolism , Structure-Activity Relationship , Sulfones/chemical synthesis , Sulfones/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...